BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23066937)

  • 1. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The self-concept of children and adolescents with neurofibromatosis type 1.
    Barton B; North K
    Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.
    Huijbregts S; Swaab H; de Sonneville L
    Dev Neuropsychol; 2010; 35(6):737-51. PubMed ID: 21038163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is executive function specifically impaired in children with neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility.
    Roy A; Barbarot S; Roulin JL; Charbonnier V; Fasotti L; Stalder JF; Le Gall D
    Appl Neuropsychol Child; 2014; 3(2):94-102. PubMed ID: 24716868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early grade repetition and inattention associated with neurofibromatosis type 1.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children.
    Biederman J; Monuteaux MC; Doyle AE; Seidman LJ; Wilens TE; Ferrero F; Morgan CL; Faraone SV
    J Consult Clin Psychol; 2004 Oct; 72(5):757-66. PubMed ID: 15482034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of neuropsychological functioning and academic achievement in children with and without signs of attention-deficit/hyperactivity disorder.
    Rennie B; Beebe-Frankenberger M; Swanson HL
    J Clin Exp Neuropsychol; 2014; 36(6):621-35. PubMed ID: 24882447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].
    Trzcińska M; Borkowska A
    Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder and Williams syndrome: shared behavioral and neuropsychological profiles.
    Rhodes SM; Riby DM; Matthews K; Coghill DR
    J Clin Exp Neuropsychol; 2011 Jan; 33(1):147-56. PubMed ID: 20700845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of neurofibromatosis type 1 on school performance.
    Krab LC; Aarsen FK; de Goede-Bolder A; Catsman-Berrevoets CE; Arts WF; Moll HA; Elgersma Y
    J Child Neurol; 2008 Sep; 23(9):1002-10. PubMed ID: 18827266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.
    Payne JM; Hyman SL; Shores EA; North KN
    Child Neuropsychol; 2011; 17(4):313-29. PubMed ID: 21347908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and cognitive subtypes of ADHD.
    August GJ; Garfinkel BD
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):739-48. PubMed ID: 2793802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.